mounjaro patent expiration date tirzepatide expiration: Drug patents expiring in 2036 Drug Patents containing Tirzepatide

That glucagon component is what separates it from Semaglutide and puts it in an interesting middle ground between single-receptor GLP-1 agonists and the newer multi-receptor compounds like Tirzepatide and Retatrutide

Tirzepatide being a dual GLP-1 and GIP agonist, it is suggested that the GIP component of dual agonism may be responsible for the additional benefit, given the potential benefit of GIP receptor agonism on peripheral insulin sensitization

Prepare for it

MS patients with diabetes should be counseled on hypoglycemia recognition, which may be challenging if autonomic neuropathy or cognitive impairment is present

However, APS patients are often on anticoagulation therapy, and tirzepatide delayed gastric emptying could theoretically affect oral anticoagulant absorption

For cardiovascular outcomes, the SELECT trial (2023) demonstrated that semaglutide 2.4 mg reduced major adverse cardiovascular events by 20% in adults with overweight or obesity and established cardiovascular disease a landmark result for the GLP-1 class